Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

A Study to Assess the Safety, Tolerability and Efficacy of IONIS-AGT-LRx in Hypertensive Participants With Uncontrolled Blood Pressure

ClinicalTrials.gov ID: NCT04714320

Public ClinicalTrials.gov record NCT04714320. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 23, 2026, 1:47 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Double-Blind, Placebo-Controlled, Phase 2 Study to Assess the Safety, Tolerability and Efficacy of IONIS-AGT-LRx, an Antisense Inhibitor of Angiotensinogen Production Administered Subcutaneously for 12 Weeks to Hypertensive Patients With Uncontrolled Blood Pressure

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study was to evaluate the effect of IONIS-AGT-LRx compared to placebo on seated automated office systolic blood pressure (SBP) from baseline to Study Day 85 in uncontrolled hypertensive participants on ≥ 3 antihypertensive medications and to evaluate the effect of IONIS-AGT-LRx on ambulatory blood pressure, seated automated office SBP, seated automated office diastolic blood pressure (DBP), and plasma angiotensinogen (AGT) at each scheduled visit in uncontrolled hypertensive participants on ≥ 3 antihypertensive medications.

Study identification

NCT ID
NCT04714320
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Ionis Pharmaceuticals, Inc.
Industry
Enrollment
160 participants

Conditions and interventions

Conditions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years to 80 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Apr 28, 2021 (Actual)
Primary completion
Jun 29, 2022 (Actual)
Completion
Oct 3, 2022 (Actual)
Last update posted
Feb 18, 2025

2021 – 2022

United States locations

U.S. sites
48
U.S. states
20
U.S. cities
47
Facility City State ZIP Site status
Pinnacle Research Group Anniston Alabama 36207 —
Central Research Associates, Inc. Birmingham Alabama 35205 —
Achieve Clinical Research, LLC Birmingham Alabama 35216 —
Cahaba Research, Inc. Pelham Alabama 35124 —
Syed Research Consultants LLC Sheffield Alabama 35660 —
Cardiology and Medicine Clinic Little Rock Arkansas 72204 —
Advanced Research Center Anaheim California 92805 —
National Research Institute - Huntington Park Huntington Park California 90255 —
RESPIRE Research La Mesa California 91942 —
Clinical Trials Research Lincoln California 95648 —
Catalina Research Institute Montclair California 91763 —
San Fernando Valley Health Institute Van Nuys California 91405 —
Creekside Endocrine Associates, PC Denver Colorado 80246 —
Chase Medical Research LLC Waterbury Connecticut 06708 —
ALL Medical Research, LLC Cooper City Florida 33024 —
Nature Coast Clinical Research - Crystal River Crystal River Florida 34429 —
East Coast Institute for Research Jacksonville Florida 32216 —
Canvas Clinical Research Lake Worth Florida 33467 —
Allied Biomedical Research Institute, Inc. Miami Florida 33155 —
AMPM Research Clinic Miami Gardens Florida 33169 —
Advanced Research Institute Inc New Port Richey Florida 34653 —
Ocala Research Institute Ocala Florida 34471 —
Progressive Medical Research Port Orange Florida 32124 —
Gwinnett Research Institute Buford Georgia 30519 —
Sandhill Research, LLC Decatur Georgia 30030 —
Georgia Institute for Clinical Research Marietta Georgia 30060 —
Eagle Clinical Research Chicago Illinois 60621 —
Clinical Investigation Specialists, Inc. - Wauconda Wauconda Illinois 60084 —
The Research Group of Lexington, LLC Lexington Kentucky 40503 —
Louisiana Heart Center Slidell Louisiana 70458 —
Clinical Trials of America, LLC - Monroe, LA West Monroe Louisiana 71291 —
BioPharm Clinical Research Caro Michigan 48723 —
Palm Research Center, Inc. Las Vegas Nevada 89148 —
NY Scientific Brooklyn New York 11235 —
Summit Research Group, LLC Stow Ohio 44224 —
Conrad Clinical Research Edmond Oklahoma 73013 —
South Oklahoma Heart Research Oklahoma City Oklahoma 73135 —
Health Concepts Research Rapid City South Dakota 57702 —
Chattanooga Research & Medicine, PLLC Chattanooga Tennessee 37404 —
Holston Medical Group Kingsport Tennessee 37660 —
North Texas Research Associates Allen Texas 75013 —
Juno Research, LL Houston Texas 77040 —
Protenium Clinical Research, LLC Hurst Texas 76054 —
Laguna Clinical Research Associates Laredo Texas 78041 —
Kalo Clinical Research Salt Lake City Utah 84102 —
Manassas Clinical Research Center Manassas Virginia 20110 —
York Clinical Research LLC Norfolk Virginia 23510 —
TPMG Clinical Research Williamsburg Virginia 23188 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 2 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT04714320, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Feb 18, 2025 · Synced Oct 23, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT04714320 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →